Role of redox-sensitive transcription factor in the progression of atherosclerosis Possible application to gene therapy.

氧化还原敏感转录因子在动脉粥样硬化进展中的作用可能应用于基因治疗。

基本信息

  • 批准号:
    14570673
  • 负责人:
  • 金额:
    $ 2.24万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2002
  • 资助国家:
    日本
  • 起止时间:
    2002 至 2003
  • 项目状态:
    已结题

项目摘要

The aim of the present study is to identify redox-sensitive transcription factors and to analyze their role in the blood vessel. Angiotensin II that induces production of reactive oxygen species activated cAMP response element binding protein (CREB), a 43KDa nuclear transcription factor, in vascular smooth muscle cells. Hydrogen peroxide (1-1202) also activated CREB, (VSMC). H_2O_2 transiently activated CREB after 15 minutes of stimulation in ERK-and p38MAPK-dependent manner. An inhibitor for epidermal growth factor receptor (EGF-R) also suppressed H_2O_2-induced activation of CREB, suggesting that transactivation of EGF-R plays an important role in the activation of CREB. Indeed, H_2O_2 induced tyrosine phosphorylation of EGF-R. Activation of CREB by All was inhibited by N-acetylcysteine, a potent antioxidant, suggesting a critical role of reactive oxygen species in All signaling. These data suggest that CREB is a redox-sensitive transcription factor. Overexpression of dominant negative CREB by an adenovirus vector decreased Bcl-2 expression in VSMC and resulted in the induction of apoptosis. Infection of adenovirus expressing dominant negative CREB suppressed neointimal formation after balloon injury of rat carotid artery with an increase in TUNEL positive cells. These data suggest that CREB is an important redox-sensitive transcription factor that mediates survival and proliferation of VSMC. And it was suggested that CREB may be a novel therapeutic target to treat vascular diseases.
本研究的目的是识别氧化还原敏感的转录因子,并分析它们在血管中的作用。血管紧张素II可诱导血管平滑肌细胞产生43 KDa的核转录因子--活性氧激活的cAMP反应元件结合蛋白(CREB)。过氧化氢(1-1202)也激活CREB(VSMC)。H_2O_2以ERK和p38MAPK依赖的方式在刺激15分钟后瞬间激活CREB。表皮生长因子受体(EGF-R)的抑制剂也能抑制H_2O_2诱导的CREB的激活,提示EGF-R的反式激活在CREB的激活中起重要作用。的确,H_2O_2诱导EGF-R酪氨酸磷酸化。有效的抗氧化剂N-乙酰半胱氨酸可抑制ALL激活CREB,提示活性氧在ALL信号转导中起关键作用。这些数据表明CREB是一个氧化还原敏感的转录因子。腺病毒载体过表达显性负性CREB可降低VSMC中Bcl2的表达,从而诱导细胞凋亡。表达显性阴性CREB的腺病毒感染可抑制大鼠颈动脉球囊损伤后新生内膜的形成,并使TUNEL阳性细胞增多。这些数据表明,CREB是一种重要的氧化还原敏感转录因子,参与VSMC的存活和增殖。提示CREB可能成为治疗血管疾病的新靶点。

项目成果

期刊论文数量(18)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Funakoshi Y, Ichiki T et al.: "Critical role of cAMP response element-binding protein (CREB) for angiotensin II-induced hypertrophy of vascular smooth muscle cells."Hypertension. 277. 18710-18717 (2002)
Funakoshi Y、Ichiki T 等人:“cAMP 反应元件结合蛋白 (CREB) 对于血管紧张素 II 诱导的血管平滑肌细胞肥大的关键作用。”高血压。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Funakoshi Y., Ichiki T et al.: "Critical role of cAMP response element-binding protein (CREB) for angiotensin II-induced hypertrophy of vascular smooth muscle cells."Journal of Biological Chemistry. 277. 18710-18717 (2002)
Funakoshi Y.、Ichiki T 等人:“cAMP 反应元件结合蛋白 (CREB) 对于血管紧张素 II 诱导的血管平滑肌细胞肥大的关键作用。”生物化学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Funakoshi Y., Ichiki T et al.: "Critical role of cAMP response element-binding protein (CREB) for angiotensin II-induced hypertrophy of vascular smooth muscle cells"Journal of Biological Chemistry. 277. 18710-18717 (2002)
Funakoshi Y.、Ichiki T 等人:“cAMP 反应元件结合蛋白 (CREB) 对于血管紧张素 II 诱导的血管平滑肌细胞肥大的关键作用”生物化学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ichiki T et al.: "A.cAMP response element binding protein mediates reactive oxygen species-induced c-fos expression."Hypertension. 42. 177-183 (2003)
Ichiki T 等人:“A.cAMP 反应元件结合蛋白介导活性氧诱导的 c-fos 表达。”高血压。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ichiki T, et al.: "A. cAMP response element binding protein mediates reactive oxygen species-induced c-fos expression."Hypertension. 42. 177-183 (2003)
Ichiki T 等人:“A. cAMP 反应元件结合蛋白介导活性氧诱导的 c-fos 表达。”高血压。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ICHIKI Toshihiro其他文献

ICHIKI Toshihiro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ICHIKI Toshihiro', 18)}}的其他基金

Role of microglia in the development of cardiovascular diseases
小胶质细胞在心血管疾病发生中的作用
  • 批准号:
    25670391
  • 财政年份:
    2013
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Development of a novel therapeutics for vascular diseases by anti-inflammatory molecules and a new gene-delivery system
通过抗炎分子和新的基因传递系统开发血管疾病的新疗法
  • 批准号:
    19590867
  • 财政年份:
    2007
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Clarification of the role of apoptosis in the formation of vascular lesion and application of apoptosis-inducing factor to the treatment of restenosis after stent implantation.
阐明细胞凋亡在血管病变形成中的作用及凋亡诱导因子在支架植入后再狭窄治疗中的应用。
  • 批准号:
    17590742
  • 财政年份:
    2005
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Regulation of phloem development by interplay of transcription factors and signaling peptides
通过转录因子和信号肽的相互作用调节韧皮部发育
  • 批准号:
    23K05802
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Evolutionary ancient transcription factors: master keys to unlock lineage differentiation?
进化的古代转录因子:解锁谱系分化的主钥匙?
  • 批准号:
    BB/X016684/1
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Research Grant
Cell fate decision by dose of transcription factors
转录因子剂量决定细胞命运
  • 批准号:
    23H02407
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular mechanisms of functional differentiation of plant cells driven by the VNS group of NAC transcription factors
NAC转录因子VNS组驱动植物细胞功能分化的分子机制
  • 批准号:
    23H02496
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Integrative analysis of the stochasticity of single-cell omics data for predicting pioneerness of transcription factors
单细胞组学数据随机性的综合分析用于预测转录因子的先驱性
  • 批准号:
    23K14165
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidating the mechanism of erythropoiesis through the search for transcription factors targeted by deubiquitinating enzyme X.
通过寻找去泛素化酶 X 靶向的转录因子来阐明红细胞生成机制。
  • 批准号:
    23K15310
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Identification of transcription factors inducing adventitious shoot formation
诱导不定芽形成的转录因子的鉴定
  • 批准号:
    23KJ1980
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
The Role of SoxE Transcription Factors in Neural Crest Cell Specialization
SoxE 转录因子在神经嵴细胞特化中的作用
  • 批准号:
    10662767
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Investigating GLI transcription factors as regulators of the pancreatic cancer microenvironment
研究 GLI 转录因子作为胰腺癌微环境的调节剂
  • 批准号:
    10681714
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Mutual reinforcement between somatic mutations and transcription factors in clonal hematopoiesis
克隆造血中体细胞突变和转录因子之间的相互强化
  • 批准号:
    10601791
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了